Western blot analysis revealed significant reductions in CD151, ITGAE, ITGB5, p-IκBα, and p-NF-κB-65 expression following ERBB4 knockdown, suggesting that ERBB4 modulates AD progression through these pathways. This evidence concerns the gene ERBB4 and Alzheimer disease.